BCP
BCPdGe 1%
BCPdGe 1.5%
BCPdSiO2
FDA
GLP
GMP
HA
HAdGe 1%
HAdGe 1.5%
MSCs
NC-MSCs
PI
SD
| Arch Craniofac Surg > Volume 27(4); 2026 > Article |
|
BCP
BCPdGe 1%
BCPdGe 1.5%
BCPdSiO2
FDA
GLP
GMP
HA
HAdGe 1%
HAdGe 1.5%
MSCs
NC-MSCs
PI
SD
Ethical approval
All animal experiments were approved by the Ethics Committee of Bila Tserkva National Agrarian University (Protocol No. 1; Conclusion No. 2, May 31, 2018) and were conducted in accordance with the Law of Ukraine “On the Protection of Animals from Cruelty” and the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes.
Author contributions
Conceptualization: Roman Palyvoda, Natalia Ulyanchich. Data curation: Anna Zhmurko, Valeryi Chemerovskyi, Tetyana Todosiuk, Alona Zlatska. Formal analysis: Anna Zhmurko. Methodology: Anna Zhmurko, Roman Palyvoda, Natalia Ulyanchich, Valeryi Chemerovskyi, Tetyana Todosiuk, Alona Zlatska. Visualization: Anna Zhmurko, Valeryi Chemerovskyi, Tetyana Todosiuk, Alona Zlatska. Writing–original draft: Anna Zhmurko. Writing–review & editing: Roman Palyvoda. Investigation: Anna Zhmurko, Natalia Ulyanchich, Valeryi Chemerovskyi, Tetyana Todosiuk, Alona Zlatska. Resources: Natalia Ulyanchich. Supervision: Roman Palyvoda. All authors read and approved the final manuscript.
| Sample |
Experimental period |
||
|---|---|---|---|
| 24 Hours | 3 Days | 5 Days | |
| Control, plastic | 97.1 ± 0.3 | 98.4 ± 0.5 | 88.8 ± 0.3 |
| No. 1 | 8.23 ± 0.15* | 12.12 ± 0.41* | 14.1 ± 0.2 |
| No. 2 | 9.15 ± 0.16* | 15.05 ± 0.51* | 24.1 ± 0.11* |
| No. 3 | 11.21 ± 0.23* | 30.15 ± 0.35* | 44.15 ± 0.35* |
| No. 4 | 8.15 ± 0.35* | ND | ND |
| No. 5 | 10.15 ± 0.35* | 26.4 ± 1.81* | 54.51 ± 2.15* |
| No. 6 | 11.09 ± 0.35* | 15.19 ± 0.16* | 25.05 ± 0.17* |
| No. 7 | 20.31 ± 0.54* | 55.15 ± 0.56* | 78.05 ± 0.19* |
| No. 8 | 9.07 ± 0.05* | ND | ND |
| No. 9 | 20.15 ± 0.35* | 8.07 ± 0.09* | ND |

![]() |
![]() |